It was reported that the stent became occluded.The patient underwent treatment with the eluvia stents on (b)(6) 2017 as part of the (b)(6) clinical trial.The target lesion, located in the middle superficial femoral artery (sfa) of the right leg had a 6mm reference vessel diameter proximally and distally, and a total length of 80mm visually estimated.The target lesion was 100% occluded and crossed through true lumen.Pre-dilatation was performed using one balloon, afterwards two 6x100mm eluvia stents were implanted.Post-dilatation was performed using one balloon, and 30% residual stenosis remained.No thrombus was seen at the end of procedure.On (b)(6) 2019 total occlusion of the implanted study stents in the left sfa was observed.The patient was hospitalized on (b)(6) 2019 and a rotarex thrombectomy as well as lysis therapy was applied.The next day, an angiography with atherectomy and drug coated balloon treatment of the target lesion was performed.The patient was discharged on (b)(6) 2019 and the event was resolved.
|